Apellis Pharmaceuticals, Inc. (APLS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:47AM EDT. Market open.
| Previous close | 47.64 |
| Open | 48.18 |
| Bid | 48.15 x 100 |
| Ask | 48.67 x 100 |
| Day's range | 48.18 - 49.99 |
| 52-week range | 19.83 - 94.75 |
| Volume | |
| Avg. volume | 1,338,464 |
| Market cap | 5.833B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Apellis Pharmaceuticals (APLS) Down 8.7% Since Last Earnings Report: Can It Rebound?
Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- GuruFocus.com
Insider Sell: Chief Business & Strategy Officer Mark Delong Sells 9,913 Shares of Apellis ...
Mark Delong, Chief Business & Strategy Officer of Apellis Pharmaceuticals Inc (NASDAQ:APLS), has sold 9,913 shares of the company on March 18, 2024, according to a recent SEC filing.
- Insider Monkey
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
© 2024 Yahoo. All rights reserved.